🇺🇸 FDA
Pipeline program

NAL ER

NAL00-107

Phase 1 small_molecule active

Quick answer

NAL ER for Healthy Participants is a Phase 1 program (small_molecule) at Trevi Therapeutics with 2 ClinicalTrials.gov record(s).

Program details

Company
Trevi Therapeutics
Indication
Healthy Participants
Phase
Phase 1
Modality
small_molecule
Status
active

Clinical trials